
The Chemours rose 10.9% from $11.25 to $12.48, behind the S&P 500's +11.2%. Its worst day was Aug 5 (−18.6%), and its low came Nov 20 at $10.48.
Nov 17, 2025 – Nov 16, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
The Chemours closed at its lowest level of the year, 6.8% below where the year started.
−2.1% · S&P 500 −1.5%
EPS of $0.05 beat the $0.02 estimate on $1.3B revenue (est. $1.3B); Q1 revenue guidance of $1.3B–$1.4B against the $1.3B consensus.
Story events cover the past 12 months · Times ET
−16.5%, on 11M shares, the year's heaviest volume · S&P 500 +0.7%
The Chemours shares rose 10.1%, while the S&P 500 fell 0.3%.
+10.1%, the year's best day · S&P 500 −0.3%
The Chemours shares rose 10.0%, while the S&P 500 rose 0.8%.
+10.0% · S&P 500 +0.8%
EPS of $0.05 beat the $-0.04 estimate on $1.4B revenue (est. $1.4B); Q2 revenue guidance of $1.6B–$1.7B against the $1.7B consensus.
−15.3% · S&P 500 +1.4%
EPS of $0.42 beat the $0.42 estimate on $1.6B revenue (est. $1.7B); FY revenue guidance of $5.9B–$6.1B against the $6.0B consensus.
−18.6%, the year's worst day · S&P 500 −0.2%
EPS of $0.21 missed the $0.26 estimate on $1.5B revenue (est. $1.5B); Q4 revenue guidance of $1.7B–$1.8B against the $1.4B consensus.
−0.5% · S&P 500 +0.3%
Where it ended: a close of $12.48 on Nov 16, 2026. Up next: Q4 2026 earnings on Feb 18, 2027 (EPS est. $0.14, revenue est. $1.4B).
As of the Nov 16, 2026 close
Replay the year: the line draws itself and stops at each of the 7 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for CC and SPY from Benzinga historical bars. Not investment advice.